A Study of TAK-103 in Adult With Solid Tumors
NCT05164666
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class
Stopped
Business decision unrelated to patient safety
Conditions
Solid Tumors
Interventions
BIOLOGICAL:
TAK-103
Sponsor
Takeda